Annual accounts receivable:
$6.92B+$360.00M(+5.48%)Summary
- As of today (May 29, 2025), ABT annual accounts receivable is $6.92 billion, with the most recent change of +$360.00 million (+5.48%) on December 31, 2024.
- During the last 3 years, ABT annual accounts receivable has risen by +$438.00 million (+6.75%).
- ABT annual accounts receivable is now -9.88% below its all-time high of $7.68 billion, reached on December 31, 2011.
Performance
ABT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$7.33B+$402.00M(+5.81%)Summary
- As of today (May 29, 2025), ABT quarterly accounts receivable is $7.33 billion, with the most recent change of +$402.00 million (+5.81%) on March 1, 2025.
- Over the past year, ABT quarterly accounts receivable has increased by +$722.00 million (+10.93%).
- ABT quarterly accounts receivable is now -4.65% below its all-time high of $7.68 billion, reached on December 31, 2011.
Performance
ABT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ABT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | +10.9% |
| 3 y3 years | +6.8% | +2.1% |
| 5 y5 years | +27.6% | +38.5% |
ABT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.4% | at high | +21.7% |
| 5 y | 5-year | at high | +27.6% | at high | +42.5% |
| alltime | all time | -9.9% | +456.5% | -4.7% | +488.8% |
ABT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $7.33B(+5.8%) |
| Dec 2024 | $6.92B(+5.5%) | $6.92B(-1.8%) |
| Sep 2024 | - | $7.05B(+2.9%) |
| Jun 2024 | - | $6.85B(+3.8%) |
| Mar 2024 | - | $6.61B(+0.6%) |
| Dec 2023 | $6.57B(+5.6%) | $6.57B(+1.0%) |
| Sep 2023 | - | $6.50B(+5.3%) |
| Jun 2023 | - | $6.17B(+2.5%) |
| Mar 2023 | - | $6.02B(-3.2%) |
| Dec 2022 | $6.22B(-4.1%) | $6.22B(-3.0%) |
| Sep 2022 | - | $6.41B(-11.0%) |
| Jun 2022 | - | $7.20B(+0.3%) |
| Mar 2022 | - | $7.18B(+10.7%) |
| Dec 2021 | $6.49B(+1.1%) | $6.49B(+1.3%) |
| Sep 2021 | - | $6.41B(+4.8%) |
| Jun 2021 | - | $6.11B(+0.3%) |
| Mar 2021 | - | $6.10B(-5.0%) |
| Dec 2020 | $6.41B(+18.2%) | $6.41B(+13.5%) |
| Sep 2020 | - | $5.65B(+9.9%) |
| Jun 2020 | - | $5.14B(-2.9%) |
| Mar 2020 | - | $5.29B(-2.5%) |
| Dec 2019 | $5.42B(+4.7%) | $5.42B(-0.5%) |
| Sep 2019 | - | $5.45B(-1.8%) |
| Jun 2019 | - | $5.55B(+3.8%) |
| Mar 2019 | - | $5.34B(+3.1%) |
| Dec 2018 | $5.18B(-1.3%) | $5.18B(-1.7%) |
| Sep 2018 | - | $5.27B(+1.5%) |
| Jun 2018 | - | $5.19B(-3.1%) |
| Mar 2018 | - | $5.36B(+2.0%) |
| Dec 2017 | $5.25B(+61.6%) | $5.25B(+9.4%) |
| Sep 2017 | - | $4.80B(+3.6%) |
| Jun 2017 | - | $4.63B(+2.7%) |
| Mar 2017 | - | $4.51B(+38.9%) |
| Dec 2016 | $3.25B(-5.0%) | $3.25B(-2.2%) |
| Sep 2016 | - | $3.32B(-6.9%) |
| Jun 2016 | - | $3.57B(+4.0%) |
| Mar 2016 | - | $3.43B(+0.4%) |
| Dec 2015 | $3.42B(-4.7%) | $3.42B(-1.2%) |
| Sep 2015 | - | $3.46B(-2.6%) |
| Jun 2015 | - | $3.55B(+2.1%) |
| Mar 2015 | - | $3.48B(-2.9%) |
| Dec 2014 | $3.59B(-10.0%) | $3.59B(-0.9%) |
| Sep 2014 | - | $3.62B(-10.8%) |
| Jun 2014 | - | $4.06B(+4.5%) |
| Mar 2014 | - | $3.88B(-2.6%) |
| Dec 2013 | $3.99B(-47.6%) | $3.99B(+2.7%) |
| Sep 2013 | - | $3.88B(-1.4%) |
| Jun 2013 | - | $3.94B(+0.5%) |
| Mar 2013 | - | $3.92B(-48.5%) |
| Dec 2012 | $7.61B(-0.9%) | $7.61B(+9.6%) |
| Sep 2012 | - | $6.95B(+2.7%) |
| Jun 2012 | - | $6.77B(-11.6%) |
| Mar 2012 | - | $7.66B(-0.3%) |
| Dec 2011 | $7.68B(+7.0%) | $7.68B(+9.1%) |
| Sep 2011 | - | $7.04B(+0.1%) |
| Jun 2011 | - | $7.04B(-1.7%) |
| Mar 2011 | - | $7.16B(-0.3%) |
| Dec 2010 | $7.18B(+9.8%) | $7.18B(+15.0%) |
| Sep 2010 | - | $6.25B(-1.4%) |
| Jun 2010 | - | $6.34B(-2.8%) |
| Mar 2010 | - | $6.52B(-0.3%) |
| Dec 2009 | $6.54B | $6.54B(+19.5%) |
| Sep 2009 | - | $5.47B(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | $5.45B(+4.3%) |
| Mar 2009 | - | $5.23B(+4.7%) |
| Sep 2008 | - | $4.99B(-3.8%) |
| Jun 2008 | - | $5.19B(+3.8%) |
| Mar 2008 | - | $5.00B(+1.0%) |
| Dec 2007 | $4.95B(+16.9%) | $4.95B(+17.5%) |
| Sep 2007 | - | $4.21B(+24.0%) |
| Jun 2007 | - | $3.40B(+3.6%) |
| Mar 2007 | - | $3.28B(-22.5%) |
| Dec 2006 | $4.23B(+18.3%) | $4.23B(+18.3%) |
| Sep 2006 | - | $3.58B(-2.6%) |
| Jun 2006 | - | $3.67B(+9.9%) |
| Mar 2006 | - | $3.34B(-6.5%) |
| Dec 2005 | $3.58B(-3.2%) | $3.58B(+11.7%) |
| Sep 2005 | - | $3.20B(-4.3%) |
| Jun 2005 | - | $3.35B(-5.4%) |
| Mar 2005 | - | $3.54B(-4.3%) |
| Dec 2004 | $3.70B(+11.6%) | $3.70B(+25.5%) |
| Sep 2004 | - | $2.95B(+3.0%) |
| Jun 2004 | - | $2.86B(-10.6%) |
| Mar 2004 | - | $3.20B(-3.4%) |
| Dec 2003 | $3.31B(+13.2%) | $3.31B(+15.0%) |
| Sep 2003 | - | $2.88B(+1.7%) |
| Jun 2003 | - | $2.83B(+2.6%) |
| Mar 2003 | - | $2.76B(-5.6%) |
| Dec 2002 | $2.93B(+4.1%) | $2.93B(+2.2%) |
| Sep 2002 | - | $2.87B(+1.4%) |
| Jun 2002 | - | $2.83B(+6.9%) |
| Mar 2002 | - | $2.64B(-6.0%) |
| Dec 2001 | $2.81B(+29.1%) | $2.81B(+4.6%) |
| Sep 2001 | - | $2.69B(+7.9%) |
| Jun 2001 | - | $2.49B(-2.5%) |
| Mar 2001 | - | $2.55B(+17.2%) |
| Dec 2000 | $2.18B(+6.0%) | $2.18B(+7.4%) |
| Sep 2000 | - | $2.03B(-0.5%) |
| Jun 2000 | - | $2.04B(+5.1%) |
| Mar 2000 | - | $1.94B(-5.6%) |
| Dec 1999 | $2.06B(+5.1%) | $2.06B(+9.2%) |
| Sep 1999 | - | $1.88B(-1.4%) |
| Jun 1999 | - | $1.91B(-3.7%) |
| Mar 1999 | - | $1.98B(+1.4%) |
| Dec 1998 | $1.96B(+9.7%) | $1.96B(+12.9%) |
| Sep 1998 | - | $1.73B(-1.5%) |
| Jun 1998 | - | $1.76B(+3.4%) |
| Mar 1998 | - | $1.70B(-4.5%) |
| Dec 1997 | $1.78B(+4.3%) | $1.78B(+4.8%) |
| Sep 1997 | - | $1.70B(-1.7%) |
| Jun 1997 | - | $1.73B(-0.1%) |
| Mar 1997 | - | $1.73B(+1.3%) |
| Dec 1996 | $1.71B(+9.3%) | $1.71B(+10.3%) |
| Sep 1996 | - | $1.55B(-5.7%) |
| Jun 1996 | - | $1.64B(+5.2%) |
| Mar 1996 | - | $1.56B(-0.0%) |
| Dec 1995 | $1.56B(+6.4%) | $1.56B(+6.3%) |
| Sep 1995 | - | $1.47B(-3.2%) |
| Jun 1995 | - | $1.52B(-1.9%) |
| Mar 1995 | - | $1.55B(+5.5%) |
| Dec 1994 | $1.47B(+9.9%) | $1.47B(-0.2%) |
| Sep 1994 | - | $1.47B(+2.7%) |
| Jun 1994 | - | $1.43B(+6.2%) |
| Mar 1994 | - | $1.35B(+1.1%) |
| Dec 1993 | $1.34B(+7.4%) | $1.34B(+7.4%) |
| Dec 1992 | $1.24B | $1.24B |
FAQ
- What is Abbott Laboratories annual accounts receivable?
- What is the all time high annual accounts receivable for Abbott Laboratories?
- What is Abbott Laboratories annual accounts receivable year-on-year change?
- What is Abbott Laboratories quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Abbott Laboratories?
- What is Abbott Laboratories quarterly accounts receivable year-on-year change?
What is Abbott Laboratories annual accounts receivable?
The current annual accounts receivable of ABT is $6.92B
What is the all time high annual accounts receivable for Abbott Laboratories?
Abbott Laboratories all-time high annual accounts receivable is $7.68B
What is Abbott Laboratories annual accounts receivable year-on-year change?
Over the past year, ABT annual accounts receivable has changed by +$360.00M (+5.48%)
What is Abbott Laboratories quarterly accounts receivable?
The current quarterly accounts receivable of ABT is $7.33B
What is the all time high quarterly accounts receivable for Abbott Laboratories?
Abbott Laboratories all-time high quarterly accounts receivable is $7.68B
What is Abbott Laboratories quarterly accounts receivable year-on-year change?
Over the past year, ABT quarterly accounts receivable has changed by +$722.00M (+10.93%)